Simian models for AIDS.

M. D. Daniel, Ronald Charles Desrosiers, N. L. Letvin, N. W. King, D. K. Schmidt, P. Sehgal, R. D. Hunt

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The macaque immunodeficiency syndrome has many parallels to AIDS in humans. Affected monkeys develop profound, prolonged T lymphocyte dysfunction and die of lymphomas or opportunistic infections. We recently isolated a virus that we call SIV from four sick macaque monkeys. The morphology, growth characteristics, and antigenic properties of this virus indicate that it is related to the causative agent of human AIDS. The pathogenicity of this newly isolated virus was tested in macaque monkeys. Five of six died between 127 and 352 days following inoculation. The animals developed a wasting syndrome and died with adenovirus pancreatitis and/or pneumonia and primary retroviral encephalitis. Immunological abnormalities in these animals included a decrease in circulating T4+ lymphocytes and depressed peripheral blood lymphocyte proliferative response to pokeweed mitogen. The SIV monkey model holds great promise for testing antiviral agents and for the development of vaccines against AIDS.

Original languageEnglish (US)
Pages (from-to)501-507
Number of pages7
JournalCancer detection and prevention. Supplement : official publication of the International Society for Preventive Oncology, Inc
Volume1
StatePublished - 1987
Externally publishedYes

Fingerprint

Simian Acquired Immunodeficiency Syndrome
Haplorhini
Macaca
Viruses
Acquired Immunodeficiency Syndrome
Wasting Syndrome
CD4-Positive T-Lymphocytes
AIDS Vaccines
Pokeweed Mitogens
Opportunistic Infections
Encephalitis
Adenoviridae
Pancreatitis
Antiviral Agents
Virulence
Lymphoma
Pneumonia
Lymphocytes
T-Lymphocytes
Growth

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Simian models for AIDS. / Daniel, M. D.; Desrosiers, Ronald Charles; Letvin, N. L.; King, N. W.; Schmidt, D. K.; Sehgal, P.; Hunt, R. D.

In: Cancer detection and prevention. Supplement : official publication of the International Society for Preventive Oncology, Inc, Vol. 1, 1987, p. 501-507.

Research output: Contribution to journalArticle

Daniel, M. D. ; Desrosiers, Ronald Charles ; Letvin, N. L. ; King, N. W. ; Schmidt, D. K. ; Sehgal, P. ; Hunt, R. D. / Simian models for AIDS. In: Cancer detection and prevention. Supplement : official publication of the International Society for Preventive Oncology, Inc. 1987 ; Vol. 1. pp. 501-507.
@article{1d3f7a87e95c47d1ac35fa3f08404bc6,
title = "Simian models for AIDS.",
abstract = "The macaque immunodeficiency syndrome has many parallels to AIDS in humans. Affected monkeys develop profound, prolonged T lymphocyte dysfunction and die of lymphomas or opportunistic infections. We recently isolated a virus that we call SIV from four sick macaque monkeys. The morphology, growth characteristics, and antigenic properties of this virus indicate that it is related to the causative agent of human AIDS. The pathogenicity of this newly isolated virus was tested in macaque monkeys. Five of six died between 127 and 352 days following inoculation. The animals developed a wasting syndrome and died with adenovirus pancreatitis and/or pneumonia and primary retroviral encephalitis. Immunological abnormalities in these animals included a decrease in circulating T4+ lymphocytes and depressed peripheral blood lymphocyte proliferative response to pokeweed mitogen. The SIV monkey model holds great promise for testing antiviral agents and for the development of vaccines against AIDS.",
author = "Daniel, {M. D.} and Desrosiers, {Ronald Charles} and Letvin, {N. L.} and King, {N. W.} and Schmidt, {D. K.} and P. Sehgal and Hunt, {R. D.}",
year = "1987",
language = "English (US)",
volume = "1",
pages = "501--507",
journal = "Cancer detection and prevention. Supplement : official publication of the International Society for Preventive Oncology, Inc",
issn = "1043-6995",

}

TY - JOUR

T1 - Simian models for AIDS.

AU - Daniel, M. D.

AU - Desrosiers, Ronald Charles

AU - Letvin, N. L.

AU - King, N. W.

AU - Schmidt, D. K.

AU - Sehgal, P.

AU - Hunt, R. D.

PY - 1987

Y1 - 1987

N2 - The macaque immunodeficiency syndrome has many parallels to AIDS in humans. Affected monkeys develop profound, prolonged T lymphocyte dysfunction and die of lymphomas or opportunistic infections. We recently isolated a virus that we call SIV from four sick macaque monkeys. The morphology, growth characteristics, and antigenic properties of this virus indicate that it is related to the causative agent of human AIDS. The pathogenicity of this newly isolated virus was tested in macaque monkeys. Five of six died between 127 and 352 days following inoculation. The animals developed a wasting syndrome and died with adenovirus pancreatitis and/or pneumonia and primary retroviral encephalitis. Immunological abnormalities in these animals included a decrease in circulating T4+ lymphocytes and depressed peripheral blood lymphocyte proliferative response to pokeweed mitogen. The SIV monkey model holds great promise for testing antiviral agents and for the development of vaccines against AIDS.

AB - The macaque immunodeficiency syndrome has many parallels to AIDS in humans. Affected monkeys develop profound, prolonged T lymphocyte dysfunction and die of lymphomas or opportunistic infections. We recently isolated a virus that we call SIV from four sick macaque monkeys. The morphology, growth characteristics, and antigenic properties of this virus indicate that it is related to the causative agent of human AIDS. The pathogenicity of this newly isolated virus was tested in macaque monkeys. Five of six died between 127 and 352 days following inoculation. The animals developed a wasting syndrome and died with adenovirus pancreatitis and/or pneumonia and primary retroviral encephalitis. Immunological abnormalities in these animals included a decrease in circulating T4+ lymphocytes and depressed peripheral blood lymphocyte proliferative response to pokeweed mitogen. The SIV monkey model holds great promise for testing antiviral agents and for the development of vaccines against AIDS.

UR - http://www.scopus.com/inward/record.url?scp=0023462484&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023462484&partnerID=8YFLogxK

M3 - Article

C2 - 3480063

AN - SCOPUS:0023462484

VL - 1

SP - 501

EP - 507

JO - Cancer detection and prevention. Supplement : official publication of the International Society for Preventive Oncology, Inc

JF - Cancer detection and prevention. Supplement : official publication of the International Society for Preventive Oncology, Inc

SN - 1043-6995

ER -